Kimberly Armstrong, Ph.D., MT (ASCP) is the Director of the Influenza and Emerging Infectious Diseases Division (IEIDD) at the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response (ASPR) at the Department for Health and Human Services. Prior to becoming the Division Director in 2023, Dr. Armstrong was the Chief of the Therapeutics Program within IEIDD. Her work within the program focused on testing antivirals for the treatment of hospitalized influenza infections and eventually pivoting the program to host-directed therapeutics for the treatment of acute respiratory distress syndrome. Before joining BARDA in 2015 as a project officer, Dr. Armstrong managed a regulatory science research portfolio for the Office of Counterterrorism and Emerging Threats at the Food and Drug Administration (FDA). Dr. Armstrong joined the federal government as a Presidential Management Fellow at the Defense Threat Reduction Agency (DTRA). She received her Ph.D. from the Harvard Graduate School of Arts and Sciences in Biological Sciences in Public Health where her work focused on drug resistance in the human immunodeficiency virus (HIV). Dr. Armstrong received her certification as a medical technologist from the American Society for Clinical Pathology.